COMP <GO>
MMM vs UNH // EV/EBITDA & P/E VALUATION
3M Company (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: MMM 7
— UNH 8
▲ EV/EBITDA & P/E VALUATION LEADER: UNH
LAST: $174.34 (-1.70%) • MKT CAP: $91.65B
valuation
18.1x
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
valuation
16.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MMM VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MMM | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 39.90% | 88.57% | -48.67 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 32.90% | 11.47% | +21.43 | MMM | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 18.1x | 16.4x | +1.65 | UNH | /valuation <GO> |
| Free Cash Flow Yield | 1.52% | 6.48% | -4.96 | UNH | /fcf-yield <GO> |
| Operating Margin | 18.60% | 4.82% | +13.78 | MMM | /operating-margins <GO> |
| Net Profit Margin | 13.00% | 3.14% | +9.86 | MMM | /net-margins <GO> |
| Revenue Growth (YoY) | 1.50% | 6.46% | -4.96 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.70% | 2.28% | -0.58 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.37 | 3.12 | +1.25 | MMM | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 6.74% | -0.14 | MMM | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 58.5 | 56.0 | +2.47 | MMM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.91 | 0.33 | +0.58 | MMM | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.2x | 17.1x | +9.11 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $91.65B | $364.66B | -$273.01B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MMM REV | UNH REV | MMM GROSS % | UNH GROSS % | MMM FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $24.95B | $447.57B | 39.9% | 88.7% | $1.40B | $16.07B |
| FY 2024 | $24.57B | $400.28B | 41.2% | 88.3% | $638.0M | $20.70B |
| FY 2023 | $24.61B | $371.62B | 44.0% | 89.6% | $5.57B | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MMM // BETA 0.91
UNH // BETA 0.33